Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | TACR1 | P25103 | 5/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.36 |
| ▸ | TDP2 | O95551 | 1/20 | 0.35 |
| ▸ | CASR | P41180 | 1/20 | 0.35 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL115139 | 0.89 | KDM4E (0.42) | BRD4SMN1; SMN2LMNAKDM4EGAA | |
| SCHEMBL115214 | 0.85 | BRD4 (0.42) | BRD4TACR1SMN1; SMN2LMNAKMT2A | |
| SCHEMBL115298 | 0.83 | METAP2 (0.35) | BRD4SMN1; SMN2KDM4EGAATP53 | |
| SCHEMBL115266 | 0.83 | METAP2 (0.35) | BRD4SMN1; SMN2LMNAKDM4EGAA | |
| SCHEMBL115176 | 0.79 | KDM4E (0.42) | BRD4TACR1SMN1; SMN2LMNAKMT2A | |
| SCHEMBL116175 | 0.71 | HEXA (0.40) | BRD4TACR1KMT2AKDM4ETDP2 | |
| SCHEMBL11965004 | 0.71 | PDE4A (0.41) | BRD4SMN1; SMN2LMNAKDM4EGAA | |
| SCHEMBL115197 | 0.71 | BRD4 (0.38) | BRD4TACR1SMN1; SMN2LMNAKMT2A | |
| SCHEMBL113860 | 0.71 | BRD4 (0.38) | BRD4TACR1SMN1; SMN2LMNAKMT2A | |
| SCHEMBL115231 | 0.71 | F7 (0.44) | BRD4TACR1SMN1; SMN2LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120058893-A1 | HERBICIDALLY ACTIVE KETOSULTAMS AND DIKETOPYRIDINES | BAYER CROPSCIENCE AG (DE) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120058893-A1 | HERBICIDALLY ACTIVE KETOSULTAMS AND DIKETOPYRIDINES | KHK, KCNA1, KCNA2 | BRD4 3524/4885TACR1 2682/4885SMN1; SMN2 4450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.